Immatics presenting at 4th TCR-based Therapies for Solid Tumors Summit
Apr 03 - Apr 05, 2023
Join us at the 4th TCR-based Therapies for Solid Tumors Summit in Boston as the must-attend forum for TCR experts to come together to share industry updates and next generation engineered approaches to boost therapy safety and efficacy.
Tuesday, April 4, 3:45 PM
- Session: Differentiating TCR Therapy Modalities to Identify & Harness their Unique Advantages
- Presentation: Advancing Development of TCR-T Cell Therapy Alongside TCR Bispecifics Modalities
- Speaker: Claudia Wagner, VP TCR Research, Immatics
Wednesday, April 5, 9:00 AM
- Session: Addressing Clinical Challenges to Accelerate the Route to Commercialization
- Presentation: Leveraging Biomarkers for Patient Stratification in Clinical Trials & Beyond
- Speaker: Andrea Mahr, Director Companion Diagnostics, Immatics
We are looking forward to meeting you!
For more information visit the event's homepage.